Hepatic Outcomes
Cross-source consensus on Hepatic Outcomes from 1 sources and 4 claims.
1 sources · 4 claims
Evidence quality
Other
Highlighted claims
- Primary outcomes include histological changes, radiological improvement, and acceptability. — Safety and efficacy of pharmacological interventions for hepatic outcomes of metabolic dysfunction-associated steatotic liver disease: protocol for systematic review and network meta-analysis
- Histological outcomes include NAFLD activity score, steatosis score, and fibrosis score. — Safety and efficacy of pharmacological interventions for hepatic outcomes of metabolic dysfunction-associated steatotic liver disease: protocol for systematic review and network meta-analysis
- Acceptability is treated as a primary endpoint because withdrawal reflects safety, tolerability, and partly efficacy. — Safety and efficacy of pharmacological interventions for hepatic outcomes of metabolic dysfunction-associated steatotic liver disease: protocol for systematic review and network meta-analysis
- Radiological outcomes include liver fat content, fibrosis improvement, and all-cause intervention discontinuation. — Safety and efficacy of pharmacological interventions for hepatic outcomes of metabolic dysfunction-associated steatotic liver disease: protocol for systematic review and network meta-analysis